Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

22.75
Delayed Data
As of May 27
 +0.45 / +2.02%
Today’s Change
10.56
Today|||52-Week Range
24.76
+38.80%
Year-to-Date
6 Stocks Set to Rise on New Analyst Coverage
May 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close22.30
Today’s open22.26
Day’s range21.89 - 22.98
Volume239,779
Average volume (3 months)268,991
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+28.42%
Earnings growth (this year)+18.60%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+260.42%
P/E ratioNM
Price/Sales13.29
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+1.45+4.05%
SAGESAGE Therapeutics In...+0.07+0.22%
INSYINSYS Therapeutics I...+0.13+0.82%
CLLSCellectis SA-0.49-1.55%
Data as of 4:01pm ET, 05/27/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$1.19
Annual revenue (last year)$42.1M
Annual profit (last year)-$182.2M
Net profit margin-432.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Chief Financial Officer &
Senior Vice President
Renee D. Gala
Corporate headquarters
George Town, George Town

Forecasts

Partner Offers

Search for Jobs